White House Proposes US FDA Slim-down

July 10, 2018

The U.S. Food and Drug Administ­ration (FDA) may soon see a reduction in size; the Trump administ­ration proposed an overhaul on June 20 that would, in part, restructure the regulatory body.
The proposal, titled “Delivering Government Solutions in the 21st Century,” suggests the removal of food safety from the FDA’s scope and the renaming of the organization to the “Federal Drug Administ­ration.”
Read more at Skin Inc >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Medical Marketing Whiz Recognized With Healthcare Digital Marketing Excellence Award
    • Allergan Presents Early Data on Skin Quality Treatments for Patients Taking Weight-Loss Medications
    • ValueCap Becomes Silver Vendor Affiliate with the American Med Spa Association
    • FDA Warning Letter Signals Increased Scrutiny of the Medical Necessity Exception for Compounded GLP-1s
    • Allergan Aesthetics Debuts AA Signature in the United States with SKIN360